
Paul A Sobotka MD FA
Heart Failure & Transplantation, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Vice President Clinical; Sensible Biotechnologies
Join to View Full Profile
500 N 21st St Apt 1017Philadelphia, PA 19130
Phone+1 650-288-8976
Dr. Sobotka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Sobotka received his medical degree from University of Illinois College of Medicine and has been in practice forever. He leads biomedical research, with a focus on innovation and invention of medical therapeutics addressing acquired cardiovascular illness. He holds patents on numerous medical diagnostics and therapeutics and has over 200 peer reviewed publications. Currently, he is vice-president of clinical research for Sensible Biotechnologies.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Cardiovascular Disease, 1983 - 1985
- University of MichiganResidency, Internal Medicine, 1980 - 1983
- University of Illinois College of MedicineClass of 1980
- Stanford UniversityBS, Chemistry, Dinkelspeil Award, 1972 - 1976
Certifications & Licensure
- MN State Medical License 2003 - 2026
- MI State Medical License 1982 - 2025
- WI State Medical License 2004 - 2025
- IL State Medical License 1983 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow, American Heart Association American Heart Association, 1996
- Fellow, American College of Physicians American College of Physicians, 1996
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsA Noninvasive System for Remote Monitoring of Left Ventricular Filling Pressures.Allan Böhm, Julia Lucka, Nikola Jajcay, Amitai Segev, Jana Jankova
JACC. Basic to Translational Science. 2025-03-01 - The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined.Haoran Jiang, Veraprapas Kittipibul, Felix Mahfoud, Michael Böhm, Paul A Sobotka
Heart Failure Reviews. 2025-03-01 - 7 citationsEfficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.Jie Wang, Yuehui Yin, Chengzhi Lu, Zhibing Lu, Jialu Hu
Eclinicalmedicine. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: